gip and glp-1 gelatin Assessing an unique collagen peptide as a first-line nutritional intervention in early glucose dysregulation: Findings from a 90-day pilot study Microdosing GLP-1/GIP for Women |

CagriSema, the combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, produced an estimated mean body weight reduction of 20.4% compared to 3.0% with placebo

Despite this simple reasoning Health Authorities rather posed a number of peremptory but questionable warnings on the early use of a wide number of anti-inflammatory drugs (Sestili and Stocchi, 2020) such as corticosteroids for their immunosuppressive activity (Veronese et al., 2020) and nonsteroidal antiinflammatory drugs (NSAIDs)

Ok, taking my biotech investor hat off now, and putting on my nutrition coach hat

Always consult healthcare providers to determine if its appropriate for you